• Imagine being able to respond to a new influenza strain within the same flu season
    with a painless and room temperature stable vaccine

Read More

  • Imagine the potential of increasing
    vaccine production at lower cost.
  • The CDC recommends over 40 vaccinations for a child by age 6.
    Imagine sparing the children over 30 needles
Vaccine Vision

Verndari was founded with the goal to eliminate needle phobia, and the need for the cold chain, with a cost-effective simple-to-use vaccination that can be mass produced.  Verndari has developed a complete single-dose vaccination kit which includes VaxiPatchTM. VaxiPatch is an “elegantly simple”...

read more
Featured Article
How to Inoculate Against Anti-Vaxxers The World Health Organization has ranked vaccine hesitancy — the growing resistance to widely available lifesaving vaccines — as one of the top 10 health threats in the world for 2019. That news will not come as a surprise in New York City, where the worst measles outbreak in decades is now underway. Nor in California or Minnesota, where similar outbreaks unfolded in 2014 and 2017, respectively. Nor in Texas, where some 60,000 children remain wholly unvaccinated thanks in part to an aggressive anti-vaccine lobby...
read more
Featured Team Member

Durga Bobba
Member of the Board of Directors

Durga has over 25 years of global commercial biopharma experience. After an initial spell as a sales representative at Parke-Davis, he took on roles of increasing responsibility at major global pharmaceutical companies including Merck, Genentech and Amgen in the areas of Marketing, Product Development, Alliance Management and Business Development.

Durga started his 15-year career at Merck & Co, Inc. in pricing and then held U.S. and global roles that included U.S. brand management, business development and emerging markets.  He ultimately joined the Vaccine Division as Sr. Director of International Commercial Operations and later Executive Director for the Eastern Europe Middle East and Africa region. Durga supported four ex-US launches and helped Merck Vaccines quadruple annual sales to $4 billion to become the world’s number one vaccine company. Durga is currently the Chief Business Officer of SutroVax.  

Durga holds an MBA from Georgetown University where he received the Dean’s Citation for distinguished service and leadership.

read more